MIR5702

Across TCGA pan-cancer cohorts, MIR5702 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR5702 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR5702 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR5702 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

KIRP, BRCA, and LUSC are the cancer types where MIR5702 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.111	0.828	<.001	90	view →
BRCA	OS	Tertile	III,IV	0.287	0.833	.002	36	view →
LUSC	OS	Tertile	All	0.329	0.678	.014	24	view →
UVM	DFS	Tertile	All	0.180	0.744	.019	18	view →
THCA	DFS	Tertile	II,III,IV	0.133	0.764	.004	18	view →
KIRC	DFS	Tertile	IV	1.000	0.475	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR5702–KIRP (OS)

Open the KIRP breakdown →